BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10787761)

  • 1. Positron emission tomography: a first-hand experience.
    Traylor J
    Radiol Manage; 2000; 22(1):41-7. PubMed ID: 10787761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The radioprotection management of a PET department with a cyclotron and radiopharmacy laboratory, in accordance with Italian legislation.
    Russo AA; Ferrari P; Casale M; Delia R
    Radiat Prot Dosimetry; 2011 Sep; 147(1-2):240-6. PubMed ID: 22039292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography: a financial and operational analysis.
    Conti PS; Keppler JS; Halls JM
    AJR Am J Roentgenol; 1994 Jun; 162(6):1279-86. PubMed ID: 8191981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography: a technology assessment of PET imaging--past, present, and future.
    Frazee D
    Radiol Manage; 2004; 26(6):38-43. PubMed ID: 15633509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost analysis of positron emission tomography.
    Keppler JS; Conti PS
    AJR Am J Roentgenol; 2001 Jul; 177(1):31-40. PubMed ID: 11418393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG PET reimbursement.
    Bietendorf J
    J Nucl Med Technol; 2004 Mar; 32(1):33-8. PubMed ID: 14990673
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiopharmaceuticals in PET imaging.
    Duncan K
    J Nucl Med Technol; 1998 Dec; 26(4):228-34; quiz 242. PubMed ID: 9884933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit.
    Wild D; Eyrich GK; Ciernik IF; Stoeckli SJ; Schuknecht B; Goerres GW
    J Craniomaxillofac Surg; 2006 Jan; 34(1):9-16. PubMed ID: 16343913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The nuclear medicine department and the TEP/Biomedical Cyclotron unit].
    Goldman S; Schoutens A; Blocklet D; Dumarey N; Egrise D; Lipschutz B; Monclus M; Moreno-Reyes R; Schmitz F; Van Naemen J; Wikler D
    Rev Med Brux; 2002; 23 Suppl 2():101-5. PubMed ID: 12584923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New radiopharmaceuticals and positron-emission tomography applications at the Masaryk Memorial Cancer Institute in Brno].
    Adam J; Andres P; Bolcák K; Cermáková M; Demlová R; Dubská L; Sedlácková S; Valík D
    Klin Onkol; 2009; 22(3):94-7. PubMed ID: 19708542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Positron emission tomography: basic principle and radionuclides/probes for metabolic/functional analysis].
    Saga T; Yoshikawa K; Ishizu K
    Rinsho Byori; 2007 Jul; 55(7):630-8. PubMed ID: 17718059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Positron-emission tomography (PET)--basic considerations].
    von Schulthess GK; Westera G; Schubiger PA
    Schweiz Rundsch Med Prax; 1993 Aug; 82(34):901-4. PubMed ID: 8372293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluate before you leap into PET/coincidence detection imaging.
    Freedman GS
    Diagn Imaging (San Franc); 1998 Nov; 20(11):167-9, 171, 173 passim. PubMed ID: 10344859
    [No Abstract]   [Full Text] [Related]  

  • 16. PET projects: providers like what they see.
    Wagner M
    Mod Healthc; 1992 Nov; 22(48):34-6, 38, 40. PubMed ID: 10122258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hurdles to technology diffusion: what are expectations for PET?
    McGivney WT
    J Nucl Med; 1991 Apr; 32(4):660-4. PubMed ID: 2013804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The business of PET/CT.
    Halliday S; Thrall JH
    AJR Am J Roentgenol; 2005 May; 184(5 Suppl):S152-5. PubMed ID: 15855084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography; making an informed decision.
    Webster W
    Radiol Manage; 1988; 10(4):37-9. PubMed ID: 10295389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introducing the PET Centre Bydgoszcz - Poland.
    Romanowicz G; Zuchora Z
    Nucl Med Rev Cent East Eur; 2003; 6(1):65-7. PubMed ID: 14600937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.